Research OutSmarts Endometriosis II Study

Part of paid clinical trials in Manhasset, New York.

Sponsor
Northwell Health
Study ID
NCT05601596
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 40 Years
Healthy Volunteers
Accepted

Interventions

  • Analysis of menstrual blood to predict endometriosis — DIAGNOSTIC_TEST
    Menstrual blood from controls and symptomatic cases will be analyzed using single cell RNA-sequencing to develop a panel of biomarkers that can be developed into a screening test or diagnostic test for endometriosis.

Study Details

This product will be used as a diagnostic test to screen for the likelihood of endometriosis in menstruating adults with symptoms suggestive of endometriosis. The purpose of the test will be to guide clinical decisions regarding: 1) whether to undergo diagnostic laparoscopy to confirm the presence of endometriosis (currently, the gold standard for diagnosing endometriosis) and/or 2) how to guide the choice of hormonal or other therapies to treat symptoms of endometriosis.

Key Dates

Start date
May 27, 2022
Status verified
Jun 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Control Participant
    Having No symptoms of Endo. Provide Menstrual samples.
  • Arm: Symptomatic participant
    Having symptoms of Endo and heading to diagnostic surgery as part of their standard of care (referred).

Primary Outcome Measure

ROSE II: Pilot study to analyze menstrual blood to predict endometriosis [ Time Frame: 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Feinstein Institutes/Northwell healthManhassetNew York11030-3816-

Find similar trials in Manhasset, NY

By condition
Endometriosis
By specialty
Women's healthFertility
By research site
Feinstein Institutes/Northwell health· Manhasset, NY

Related Studies